Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +29,500 29,500
2025-06-11 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +24,150 24,150
2024-06-14 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +23,000 23,000
2023-06-16 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +21,520 21,520
2022-06-17 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +21,520 21,520
2022-06-16 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +21,520 21,520
2021-06-09 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +21,520 21,520

Page 1 of 1 · 7 trades